SPONSOR
China National Center for Cardiovascular Diseases
Total Trials
7
Recruiting
7
Phases
Phase 4
Conditions studied: HypertensionHyperglycemiaHyperlipidemiaHyperuricemiaDigital InterventionSecondary Prevention of Coronary Heart DiseasePremature Coronary Heart DiseaseNon-paroxysmal Atrial FibrillationPulmonary Artery HypertensionAortic Stenosis
China National Center for Cardiovascular Diseases is a clinical research sponsor with 7 registered studies on ClinicalTrials.gov, of which 7 are actively recruiting participants. Research covers conditions including Hypertension, Hyperglycemia, Hyperlipidemia, Hyperuricemia.
The trial portfolio spans Phase 4 studies, reflecting a pipeline that may include early-stage safety evaluations, mid-stage efficacy assessments, and large-scale confirmatory trials. All studies listed here are sourced directly from ClinicalTrials.gov and updated daily.
Frequently Asked Questions — China National Center for Cardiovascular Diseases
How many clinical trials has China National Center for Cardiovascular Diseases sponsored?
ClinicalMetric currently tracks 7 clinical trials sponsored by China National Center for Cardiovascular Diseases, of which 7 are actively recruiting participants. These trials cover conditions including Hypertension, Hyperglycemia, Hyperlipidemia. Trial counts are updated daily from ClinicalTrials.gov and reflect currently registered studies.
What therapeutic areas does China National Center for Cardiovascular Diseases research focus on?
China National Center for Cardiovascular Diseases clinical trials span Hypertension, Hyperglycemia, Hyperlipidemia, Hyperuricemia, Digital Intervention, and additional conditions. The research pipeline includes Phase 4 trials, reflecting work from early-stage safety evaluation through large-scale efficacy studies.
How do I participate in a China National Center for Cardiovascular Diseases clinical trial?
To participate in a China National Center for Cardiovascular Diseases trial, review the active studies listed on this page, check each trial's specific eligibility criteria on ClinicalTrials.gov, and contact the trial site directly—not the sponsor's headquarters. Trial sites are academic medical centers, hospitals, or specialized research clinics. Your physician can facilitate a referral. ClinicalMetric lists all China National Center for Cardiovascular Diseases trials with current recruitment status updated daily.
Clinical Trials by China National Center for Cardiovascular Diseases
NCT07400549
Recruiting
Prospective Exploratory Study on the Comprehensive Application Effectiveness of Exercise Prescription Decision Support Tools in the Management of Patients With "Four Highs" (Hypertension, Hyperglycemia, Hyperlipidemia, Hyperuricemia)
Hypertension
NCT07259278
Recruiting
Intelligent Management Platform for Guiding Exercise Rehabilitation in Coronary Heart Disease Patients
Secondary Prevention of Coronary Heart Disease
NCT07031531
Recruiting
Effectiveness of an AI-Enabled Stratified Management System for Premature Coronary Artery Disease
Premature Coronary Heart Disease
NCT06021808
Recruiting
LAA Clipping Versus NOACs to Prevent Stroke in Non-paroxysmal Atrial Fibrillation.
Non-paroxysmal Atrial Fibrillation
NCT06429579
Recruiting
Potts-shunt for the Treatment of Pediatric Patients With Severe Pulmonary Hypertension
Pulmonary Artery Hypertension
NCT06743568
Recruiting
Efficacy of Self-expandable and Balloon-expandable Valves in Patients With Ascending Aortic Dilation
Aortic Stenosis
NCT06055452 Phase 4
Recruiting
Effects of SGLT2 Inhibitors in Pre-heart Failure Populations With Hypertension
Pre-Heart Failure
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: July 2026 · Data Methodology